Cross-Sector entity
All 1 tracked stories fall under one category: pharma. Health Security Policy Academy is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Cross-Sector story that mention US Centers for Disease Control and Prevention (CDC), all published on July 12, 2026.
1 verified story tracked
Last mentioned: Jul 12, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: pharma. Health Security Policy Academy is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Cross-Sector story that mention US Centers for Disease Control and Prevention (CDC), all published on July 12, 2026. Each carries 4 original sources on average.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering US Centers for Disease Control and Prevention (CDC). Shared-story counts are live from our verified record — not editorial picks.
For biopharma manufacturers, the restructuring of PEPFAR and the September award expirations threaten high-volume procurement contracts and stable antiretroviral demand. The cliff could disrupt clinical trial infrastructure, inventory planning, and generic drug production that have relied on predictable US funding for over two decades.
Source: edition.cnn.com · cbs58.com
